These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21469210)

  • 1. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
    Arabia G; Quattrone A
    Mov Disord; 2011 Jul; 26(8):1575-6; author reply 1576. PubMed ID: 21469210
    [No Abstract]   [Full Text] [Related]  

  • 2. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
    Longoni G; Agosta F; Kostić VS; Stojković T; Pagani E; Stošić-Opinćal T; Filippi M
    Mov Disord; 2011 Feb; 26(2):247-55. PubMed ID: 21412831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism.
    Srulijes K; Reimold M; Liscic RM; Bauer S; Dietzel E; Liepelt-Scarfone I; Berg D; Maetzler W
    Mov Disord; 2012 Jan; 27(1):151-5. PubMed ID: 22359740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy.
    Talai AS; Sedlacik J; Boelmans K; Forkert ND
    Neuroimage Clin; 2018; 20():1037-1043. PubMed ID: 30342392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of MRI parameters in pure akinesia with gait freezing.
    Nakahara K; Nakane S; Kitajima M; Masuda-Narita T; Matsuo H; Ando Y
    J Neurol; 2020 Mar; 267(3):752-759. PubMed ID: 31745723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease.
    Lee YE; Williams DR; Anderson JF
    J Neuropsychol; 2016 Mar; 10(1):1-14. PubMed ID: 25223526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex.
    Geddes JF; Hughes AJ; Lees AJ; Daniel SE
    Brain; 1993 Feb; 116 ( Pt 1)():281-302. PubMed ID: 8453463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can mid-sagittal MRI be used to diagnose progressive supranuclear palsy?
    Reich SG
    Nat Clin Pract Neurol; 2006 Jan; 2(1):12-3. PubMed ID: 16932511
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease.
    Somme J; Gómez-Esteban JC; Tijero B; Berganzo K; Lezcano E; Zarranz JJ
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1230-3. PubMed ID: 23253819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson's disease.
    Kim BC; Choi SM; Choi KH; Nam TS; Kim JT; Lee SH; Park MS; Yoon W
    Neurol Sci; 2017 Apr; 38(4):627-633. PubMed ID: 28078564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalamic hypoperfusion in early stage of progressive supranuclear palsy (Richardson's syndrome): report of an autopsy-confirmed case.
    Kobayashi Z; Akaza M; Ishihara S; Tomimitsu H; Inadome Y; Arai T; Akiyama H; Shintani S
    J Neurol Sci; 2013 Dec; 335(1-2):224-7. PubMed ID: 24075472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive supranuclear palsy and Parkinson's disease overlap: A clinicopathological case report.
    Araki K; Sumikura H; Matsudaira T; Sugiura A; Takao M; Murayama S; Obi T
    Neuropathology; 2016 Apr; 36(2):187-91. PubMed ID: 26388542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
    Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
    Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
    Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
    Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants.
    Street D; Malpetti M; Rittman T; Ghosh BCP; Murley AG; Coyle-Gilchrist I; Passamonti L; Rowe JB
    Brain Commun; 2021; 3(3):fcab206. PubMed ID: 34541533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease.
    Hardman CD; Halliday GM
    Exp Neurol; 1999 Jul; 158(1):135-42. PubMed ID: 10448425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.